Antiplatelet Therapy After PCI: DAPT Duration & Surgery Timing
How long two antiplatelets stay on board, and when surgery can safely stop them
DAPT: mechanism and duration
Two targets. Aspirin irreversibly acetylates COX-1 and blocks thromboxane A2 for the 7–10-day life of the platelet; within DAPT it is dosed at 81 mg (75–100 mg) daily. P2Y12 inhibitors block ADP signaling that activates GP IIb/IIIa. Clopidogrel and prasugrel are irreversible thienopyridine prodrugs, ticagrelor is a reversible, directly active drug taken twice daily, and IV cangrelor wears off so quickly that platelet function returns within about an hour.
Why drug-eluting stents need longer DAPT. DES elute antiproliferative drugs (everolimus, zotarolimus, sirolimus) that suppress neointimal hyperplasia and cut restenosis, but they delay endothelial coverage of the struts and leave thrombogenic metal exposed longer. Restenosis creeps in as recurrent exertional angina months later; stent thrombosis is an abrupt occlusion that presents as STEMI.
| Scenario | Duration | Usual P2Y12 inhibitor |
|---|---|---|
| ACS treated with PCI | ~12 months | Ticagrelor or prasugrel, preferred over clopidogrel |
| ACS managed medically or with CABG | ~12 months | Clopidogrel or ticagrelor (not prasugrel for medical therapy); resume after CABG |
| Elective PCI, drug-eluting stent | ~6 months | Clopidogrel |
| Elective PCI, bare-metal stent | ≥1 month | Clopidogrel |
Premature P2Y12 discontinuation is the strongest predictor of stent thrombosis — a STEMI in the stented territory with high mortality that needs emergent angiography and PCI. DAPT should never be stopped early without the cardiologist's input.
P2Y12 inhibitors compared
| Agent | Pharmacology | Stop before surgery | Key cautions |
|---|---|---|---|
| Clopidogrel | Prodrug activated by CYP2C19; irreversible | 5 days | Poor metabolizers; omeprazole and esomeprazole interaction |
| Prasugrel | Prodrug, activation barely CYP2C19-dependent; irreversible; more potent | 7 days | Contraindicated after stroke/TIA; avoid at ≥75 y; 5 mg if <60 kg; give only once PCI is planned |
| Ticagrelor | Active drug; reversible; twice daily | 3 to 5 days | Dyspnea, bradyarrhythmias, ↑uric acid; aspirin ≤100 mg; strong CYP3A4 inhibitors/inducers; prior intracranial hemorrhage |
| Cangrelor | IV, active, offset within ~1 hour | Hours before (as a bridge) | Used during PCI and as a perioperative bridge |
Clopidogrel pharmacogenomics. Hepatic CYP2C19 performs both oxidation steps that turn clopidogrel into its active thiol metabolite. Loss-of-function alleles (*2, *3) create poor metabolizers — more common in East Asian populations — with weak platelet inhibition and more stent thrombosis, the subject of a boxed warning. Switch these patients to prasugrel or ticagrelor; doubling the clopidogrel dose does not overcome the defect.
The PPI interaction. Omeprazole and esomeprazole inhibit CYP2C19 and reduce clopidogrel's active metabolite (cimetidine does too). A PPI is recommended for DAPT patients with prior GI bleeding and reasonable with older age or concurrent anticoagulant, steroid, or NSAID use; pantoprazole is the preferred choice.
Ticagrelor dyspnea. About 1 in 7 patients develop dyspnea, attributed to raised adenosine levels. It is usually mild and often fades; once heart failure and bronchospasm are excluded, reassure, and switch agents only if it is intolerable.
Three P's argue against prasugrel: Past stroke or TIA (absolute), Pensioners ≥75, and Petite patients under 60 kg (5 mg dose).
Surgery in a stented patient
- Can it be done on DAPT?Dental extractions, cataract surgery, and minor skin procedures proceed on both agents with local hemostasis.
- Is it elective?Wait ≥30 days after a bare-metal stent and ideally ≥6 months after a DES (12 months after an ACS stent when feasible). If delay is riskier, as with cancer surgery, a DES patient may proceed after 3 months — never sooner if the P2Y12 inhibitor must stop.
- Stop the P2Y12 inhibitorClopidogrel 5 days, ticagrelor 3 to 5 days, prasugrel 7 days before surgery.
- Continue aspirinUnless bleeding would be catastrophic: intracranial, spinal canal, or posterior eye chamber surgery.
- Restart promptlyResume the P2Y12 inhibitor as soon as hemostasis allows, ideally within 24–48 hours.
When surgery cannot wait. Emergency surgery proceeds on DAPT, with platelet transfusion for serious bleeding; transfused platelets work less well while reversible ticagrelor still circulates. For urgent surgery in the highest-risk window, such as within a month of stenting, an IV cangrelor infusion can bridge the days off the oral agent.
Atrial fibrillation after PCI
Avoid prolonged triple therapy. Combining an anticoagulant with aspirin and a P2Y12 inhibitor sharply raises bleeding. The preferred strategy is a DOAC (less bleeding than warfarin) plus clopidogrel; prasugrel is avoided alongside an anticoagulant, and ticagrelor is reserved for very high thrombotic risk. Aspirin is stopped after about 1 week, or up to 30 days when thrombotic risk is high.
Long term. Continue the DOAC plus clopidogrel to about 12 months, then DOAC monotherapy indefinitely — DAPT alone does not prevent AF-related stroke.